eXoZymes (EXOZ) Stock Chart & Stock Price History $13.29 -0.01 (-0.08%) As of 12:26 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock eXoZymes Stock Price Performance The eXoZymes (EXOZ) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 11.12%, reflecting recent market activity. As of the latest close, eXoZymes traded at $13.30 with a market cap of $111.59 million and volume of 1,192 shares. Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-5.07%1 Month Performance+11.12%3 Month Performance+34.11% EXOZ Stock Chart for Monday, October, 6, 2025 EXOZ Chart by TradingView eXoZymes Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$13.31$13.30-0.08%$13.30$12.781,192 shs$111.59 million10/02/2025$14.00$13.31-4.93%$13.31$13.161,947 shs$111.67 million10/01/2025$14.43$14.00-2.98%$14.00$13.50950 shs$117.42 million09/30/2025$14.50$14.43-0.48%$14.90$14.013,936 shs$121.07 million09/29/2025$15.48$14.50-6.33%$15.70$14.503,591 shs$121.66 million09/26/2025$14.57$15.48+6.25%$16.61$14.919,963 shs$129.88 million09/25/2025$14.60$14.57-0.21%$14.57$14.57984 shs$122.20 million09/24/2025$14.60$14.60$15.00$14.602,448 shs$122.49 million09/23/2025$14.60$14.60$15.00$14.602,448 shs$122.49 million09/22/2025$14.47$14.60+0.90%$15.00$13.117,206 shs$122.45 million Get the Latest News and Ratings for EXOZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$13.75$14.47+5.24%$14.70$13.7811,532 shs$121.36 million09/18/2025$13.62$13.75+0.95%$13.78$13.392,838 shs$115.36 million09/17/2025$13.09$13.62+4.05%$13.62$13.091,452 shs$114.27 million09/16/2025$13.49$13.09-2.97%$13.09$13.061,253 shs$109.79 million09/15/2025$12.40$13.49+8.79%$13.49$12.501,217 shs$113.18 million09/12/2025$12.40$12.40$12.40$12.403,371 shs$104.04 million09/11/2025$12.40$12.40$13.03$11.866,586 shs$104.04 million09/10/2025$11.76$12.40+5.44%$13.03$11.866,586 shs$104.00 million09/09/2025$12.00$11.76-2.00%$11.76$11.76690 shs$98.67 million09/08/2025$11.96$12.00+0.33%$12.00$10.951,730 shs$100.68 million09/05/2025$10.57$11.96+13.15%$12.00$11.007,095 shs$100.34 million Related Companies Solid Biosciences Stock Chart Corvus Pharmaceuticals Stock Chart Compass Therapeutics Stock Chart REGENXBIO Stock Chart Ocugen Stock Chart CryoPort Stock Chart Monopar Therapeutics Stock Chart iTeos Therapeutics Stock Chart Fulcrum Therapeutics Stock Chart Alumis Stock Chart Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXOZ) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eXoZymes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eXoZymes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
